Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder

Title
Efficacy and Safety of Levomilnacipran Sustained Release 40 mg, 80 mg, or 120 mg in Major Depressive Disorder
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PSYCHIATRY
Volume 74, Issue 03, Pages 242-248
Publisher
Physicians Postgraduate Press, Inc
Online
2013-03-19
DOI
10.4088/jcp.12m08197

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now